Skip to main content
Top
Published in: Clinical & Experimental Metastasis 1/2011

01-01-2011 | Research Paper

Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation condition

Authors: Na Zhang, Wen-Jian Zhang, Han-Qing Cai, Hong-Lin Liu, Liang Peng, Cheng-Hui Li, Li-Ya Ye, Shi-Qing Xu, Zhi-Hua Yang, Jin-Ning Lou

Published in: Clinical & Experimental Metastasis | Issue 1/2011

Login to get access

Abstract

To investigate the relevant molecular mechanisms of platelet in promoting metastasis of tumor cell. The adhesion of fluorescence dye labeled-platelet to human liver sinusoidal endothelial cell (LSEC) line and tumor cell lines were detected by fluorescence microscope and fluorescence plate reader or laser scanning confocal microscope. The relevant adhesion molecules were analyzed by the antibody blockage experiment. The immune colloidal gold transmission electron microscope (TEM), flow cytometry and dye transfer were used to decipher the adhesion and fusion of platelet and LSEC. The tumor cells adhesion to vessels in ischemia condition was analyzed on mouse mesenteric vessels and the metastasis and neovascularization of metastatic foci in pulmonary tissue were also detected after tumor cells injected into nude mice via tail veil. After hypoxia-reoxygenation, tumor cell or LSEC markedly increased its adhesion with platelet, which could be blocked by different antibodies to platelet adhesion molecules. Platelet increased adhesion of tumor cell to LSEC in dose-dependent manner. The fusion of platelet and LSEC was demonstrated by translocation of fluorescent dye from platelet into the adherent LSEC; gpIIb emerged on the LSEC; and confirmed by TEM. The morphological examination found platelet presented between tumor cell and LSEC. Animal experiment indicated that the tumor adhesion to vessels was seldom in normal condition, but increased in ischemia-reperfusion condition, and further significantly enhanced by platelets. The number of tumor metastatic foci and the density of blood vessels within metastatic foci in lung were markedly increased by tumor cell pre-adhered with platelet. The adhesion or fusion of platelet to endothelial cell mediated by platelet surface adhesion molecules, which could promote the adhesion of tumor cell with endothelial cells and the tumor metastasis.
Literature
1.
go back to reference Lerner DL, Walsh CS, Cass I et al (2007) The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol 104(1):91–94CrossRefPubMed Lerner DL, Walsh CS, Cass I et al (2007) The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol 104(1):91–94CrossRefPubMed
2.
go back to reference Tomita M, Shimizu T, Hara M et al (2008) Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg 7(4):613–615CrossRefPubMed Tomita M, Shimizu T, Hara M et al (2008) Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg 7(4):613–615CrossRefPubMed
3.
go back to reference Suppiah R, Shaheen PE, Elson P et al (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107(8):1793–1800CrossRefPubMed Suppiah R, Shaheen PE, Elson P et al (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107(8):1793–1800CrossRefPubMed
4.
go back to reference Ikeda M, Furukawa H, Imamura H et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9(3):287–291CrossRefPubMed Ikeda M, Furukawa H, Imamura H et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9(3):287–291CrossRefPubMed
5.
go back to reference Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8(8):1247–1255CrossRefPubMed Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8(8):1247–1255CrossRefPubMed
6.
go back to reference Pearlstein E, Ambrogio C, Karpatkin S (1984) Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res 44(9):3884–3887PubMed Pearlstein E, Ambrogio C, Karpatkin S (1984) Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res 44(9):3884–3887PubMed
7.
go back to reference Francis JL, Amirkhosravi A (2002) Effect of antihemostatic agents on experimental tumor dissemination. Semin Thromb Hemost 28(1):29–38CrossRefPubMed Francis JL, Amirkhosravi A (2002) Effect of antihemostatic agents on experimental tumor dissemination. Semin Thromb Hemost 28(1):29–38CrossRefPubMed
8.
go back to reference Amirkhosravi A, Amaya M, Siddiqui F et al (1999) Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. Platelet 10(5):285–292CrossRef Amirkhosravi A, Amaya M, Siddiqui F et al (1999) Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. Platelet 10(5):285–292CrossRef
9.
go back to reference Troxler M, Dickinson K, Homer-Vanniasinkam S (2007) Platelet function and antiplatelet therapy. Br J Surg 94(6):674–682CrossRefPubMed Troxler M, Dickinson K, Homer-Vanniasinkam S (2007) Platelet function and antiplatelet therapy. Br J Surg 94(6):674–682CrossRefPubMed
10.
go back to reference Sierko E, Wojtukiewicz MZ (2007) Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin Thromb Hemost 33(7):712–721CrossRefPubMed Sierko E, Wojtukiewicz MZ (2007) Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin Thromb Hemost 33(7):712–721CrossRefPubMed
11.
go back to reference Jain S, Zuka M, Liu JL et al (2007) Platelet glycoprotein Ib (alpha) supports experimental lung metastasis. Proc Natl Acad Sci USA 104(21):9024–9028CrossRefPubMed Jain S, Zuka M, Liu JL et al (2007) Platelet glycoprotein Ib (alpha) supports experimental lung metastasis. Proc Natl Acad Sci USA 104(21):9024–9028CrossRefPubMed
12.
go back to reference Trikha M, Raso E, Cai Y et al (1998) Role of alphaII(b)beta3 integrin in prostate cancer metastasis. Prostate 35(3):185–192CrossRefPubMed Trikha M, Raso E, Cai Y et al (1998) Role of alphaII(b)beta3 integrin in prostate cancer metastasis. Prostate 35(3):185–192CrossRefPubMed
13.
go back to reference Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295–1300PubMed Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295–1300PubMed
14.
go back to reference Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrinogen increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105(1):178–185CrossRefPubMed Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrinogen increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105(1):178–185CrossRefPubMed
15.
go back to reference Ma L, Perini R, McKnight W et al (2005) Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 102(1):216–220CrossRefPubMed Ma L, Perini R, McKnight W et al (2005) Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 102(1):216–220CrossRefPubMed
16.
go back to reference Li JJ, Huang YQ, Basch R et al (2001) Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 85(2):204–206PubMed Li JJ, Huang YQ, Basch R et al (2001) Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 85(2):204–206PubMed
17.
go back to reference Sierko E, Wojtukiewicz MZ (2004) Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30(1):95–108CrossRefPubMed Sierko E, Wojtukiewicz MZ (2004) Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30(1):95–108CrossRefPubMed
18.
go back to reference Pinedo HM, Verheul HM, D’Amato RJ et al (1998) Involvement of platelets in tumor angiogenesis? Lancet 352(9142):1775–1777CrossRefPubMed Pinedo HM, Verheul HM, D’Amato RJ et al (1998) Involvement of platelets in tumor angiogenesis? Lancet 352(9142):1775–1777CrossRefPubMed
19.
go back to reference Salmon P, Oberholzer J, Occhiodoro T et al (2000) Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2(4):404–414CrossRefPubMed Salmon P, Oberholzer J, Occhiodoro T et al (2000) Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2(4):404–414CrossRefPubMed
20.
go back to reference Nierodzik ML, Plotkin A, Kajumo F et al (1991) Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Investig 87(1):229–236CrossRefPubMed Nierodzik ML, Plotkin A, Kajumo F et al (1991) Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Investig 87(1):229–236CrossRefPubMed
21.
go back to reference Amirkhosravi A, Mousa SA, Amaya M (2003) Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 90(3):549–554PubMed Amirkhosravi A, Mousa SA, Amaya M (2003) Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 90(3):549–554PubMed
22.
go back to reference Dardik R, Savion N, Kaufmann Y et al (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 77(12):2069–2075PubMed Dardik R, Savion N, Kaufmann Y et al (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 77(12):2069–2075PubMed
23.
go back to reference Alonso-Escolano D, Strongin AY, Chung AW et al (2004) Membrane type-1 matrix metalloproteinase stimulates tumor cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 141(2):241–252CrossRefPubMed Alonso-Escolano D, Strongin AY, Chung AW et al (2004) Membrane type-1 matrix metalloproteinase stimulates tumor cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 141(2):241–252CrossRefPubMed
24.
go back to reference McCarty OJ, Mousa SA, Bray PF et al (2000) Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96(5):1789–1797PubMed McCarty OJ, Mousa SA, Bray PF et al (2000) Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96(5):1789–1797PubMed
25.
go back to reference Stone JP, Wagner DD (1993) P-selectin mediates adhesion of P-selectin to neuroblastoma and small cell lung cancer. J Clin Investig 92(2):804–813CrossRefPubMed Stone JP, Wagner DD (1993) P-selectin mediates adhesion of P-selectin to neuroblastoma and small cell lung cancer. J Clin Investig 92(2):804–813CrossRefPubMed
26.
go back to reference Ma YQ, Geng JG (2002) Obligatory requirement of sulfation for P-selectin binding to human salivary gland carcinoma Acc-M cells and breast carcinoma ZR-75-30 cells. J Immunol 168(4):1690–1696PubMed Ma YQ, Geng JG (2002) Obligatory requirement of sulfation for P-selectin binding to human salivary gland carcinoma Acc-M cells and breast carcinoma ZR-75-30 cells. J Immunol 168(4):1690–1696PubMed
27.
go back to reference Yang H, Majno P, Morel P et al (2002) Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 64(1):94–103CrossRefPubMed Yang H, Majno P, Morel P et al (2002) Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 64(1):94–103CrossRefPubMed
28.
go back to reference Frenette PS, Johnson RC, Hynes RO et al (1995) Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92(16):7450–7454CrossRefPubMed Frenette PS, Johnson RC, Hynes RO et al (1995) Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92(16):7450–7454CrossRefPubMed
29.
go back to reference Romo GM, Dong JF, Schade AJ et al (1999) The glycoprotein Ib-IX-V complex is a platelet counter receptor for P-selectin. J Exp Med 190(6):803–814CrossRefPubMed Romo GM, Dong JF, Schade AJ et al (1999) The glycoprotein Ib-IX-V complex is a platelet counter receptor for P-selectin. J Exp Med 190(6):803–814CrossRefPubMed
30.
go back to reference Bombeli T, Schwartz BR, Harlan JM (1998) Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187(3):329–339CrossRefPubMed Bombeli T, Schwartz BR, Harlan JM (1998) Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187(3):329–339CrossRefPubMed
31.
go back to reference Frenette PS, Moyna C, Hartwell DW et al (1998) Platelet-endothelial interactions in inflamed mesenteric venules. Blood 91(4):1318–1324PubMed Frenette PS, Moyna C, Hartwell DW et al (1998) Platelet-endothelial interactions in inflamed mesenteric venules. Blood 91(4):1318–1324PubMed
32.
go back to reference Rosenblum WI, Nelson GH, Wormley B et al (1996) Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 27(4):709–711PubMed Rosenblum WI, Nelson GH, Wormley B et al (1996) Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 27(4):709–711PubMed
33.
go back to reference Wojcik JD, Van Horn DL, Webber AJ et al (1969) Mechanism whereby platelets support the endothelium. Transfusion 9(6):324–335CrossRefPubMed Wojcik JD, Van Horn DL, Webber AJ et al (1969) Mechanism whereby platelets support the endothelium. Transfusion 9(6):324–335CrossRefPubMed
34.
go back to reference Lou J, Donati YR, Juillard P et al (1997) Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol 151(5):1397–1405PubMed Lou J, Donati YR, Juillard P et al (1997) Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol 151(5):1397–1405PubMed
35.
go back to reference Grau GE, Tacchini-Cottier F, Vesin C et al (1993) TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw 4(6):415–419PubMed Grau GE, Tacchini-Cottier F, Vesin C et al (1993) TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw 4(6):415–419PubMed
36.
go back to reference Li AJ, Madden AC, Cass I et al (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92(1):211–214CrossRefPubMed Li AJ, Madden AC, Cass I et al (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92(1):211–214CrossRefPubMed
37.
go back to reference Zeimet AG, Marth C, Muller HE et al (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170(2):549–554PubMed Zeimet AG, Marth C, Muller HE et al (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170(2):549–554PubMed
38.
go back to reference Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9(9):1826–1830CrossRefPubMed Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9(9):1826–1830CrossRefPubMed
Metadata
Title
Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation condition
Authors
Na Zhang
Wen-Jian Zhang
Han-Qing Cai
Hong-Lin Liu
Liang Peng
Cheng-Hui Li
Li-Ya Ye
Shi-Qing Xu
Zhi-Hua Yang
Jin-Ning Lou
Publication date
01-01-2011
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 1/2011
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9353-9

Other articles of this Issue 1/2011

Clinical & Experimental Metastasis 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine